Articles From: Oracle Introduces Oracle's Primavera Gateway to Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013


2013/4/8
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1004142&ProfileId=051205&sourceType=1 DENVER, CO --
Sign-up for Oracle Introduces Oracle's Primavera Gateway investment picks
2013/3/5
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=992795&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Introduces the Oracle Database Appliance X3-2 investment picks
2013/5/13
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1016569&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Optimizes Mobile Access to Campus Business Processes, Improving the Student Experience investment picks
2013/1/29
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979279&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle PartnerNetwork Launches Modern Marketing Enablement Series investment picks
2013/1/31
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980432&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Partners Introduce First Oracle Accelerate Solutions for Oracle Fusion Applications investment picks
2013/4/1
Perficient, Inc. (NASDAQ: PRFT) , a leading information technology consulting firm serving Global 2000 and other large enterprise customers throughout North America, today announced it will serve as a Two Star Elite sponsor and present on Oracle technologies and applications at Oracle’s COLLABORATE 13 conference .
Sign-up for Oracle Platinum Partner Perficient to Provide Insights on Oracle Applications and Technology at COLLABORATE 13 investment picks
2013/3/7
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=993562&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Oracle Provides Industry's First One-Stop Platform for Monitoring and Managing Improved Social Interactions and Experiences investment picks
2013/3/18
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=997475&ProfileId=051205&sourceType=1 INDIANAPOLIS, IN --
Sign-up for Oracle Releases Oracle's PeopleSoft 9.2 investment picks
2013/2/6
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=982384&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Releases Oracle's PeopleSoft PeopleTools 8.53 investment picks
2013/3/20
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=998307&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Reports Q3 GAAP EPS Up 6% to 52 Cents; Q3 Non-GAAP EPS Up 5% to 65 Cents investment picks
2013/3/20
SAN FRANCISCO (MarketWatch) — Oracle Corp.
Sign-up for Oracle sales miss targets; shares slump investment picks
2013/3/6
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=993398&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Sets the Date for Its Third Quarter Fiscal Year 2013 Earnings Announcement investment picks
2013/1/31
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980394&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Ships Over 3 Exabytes of Media for StorageTek T10000C Tape Drives investment picks
2013/2/4
http://media.marketwire.com/attachments/201205/46204_acmepacket.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981504&ProfileId=051205&sourceType=1 BEDFORD, MA --
Sign-up for Oracle to Buy Acme Packet investment picks
2013/2/6
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=982491&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Unveils New Version of Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service investment picks
2013/3/26
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1001004&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Unveils SPARC Servers With the World's Fastest Microprocessor investment picks
2013/1/29
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979236&ProfileId=051205&sourceType=1 BROOMFIELD, CO --
Sign-up for Oracle's JD Edwards EnterpriseOne Introduces Integrated and Comprehensive Solution for Health and Safety Incident Management investment picks
2013/1/31
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980348&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle's PeopleSoft Named Best in KLAS for Financials/ERP Software in Healthcare for the Second Year in a Row investment picks
2013/1/30
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979773&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle's SPARC T4 Servers Power Mission-Critical Workloads in Over 3,000 Enterprises investment picks
2013/4/8
Oragenics, Inc. (OTCBB: OGEN) (the “Company”) announced today that its common stock has been approved for listing on the NYSE Euronext's NYSE MKT .
Sign-up for Oragenics Announces Approval of Common Stock Listing on NYSE MKT investment picks
2013/2/11
Oragenics, Inc .
Sign-up for Oragenics CEO To Present at The BIO CEO & Investor Conference on February 12th 2013 investment picks
2013/2/11
Oragenics, Inc .
Sign-up for Oragenics Receives European Union CPNP Notifications for ProBiora3® Cosmetic Tablets investment picks
2013/5/31
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG) , today announced that the European Medicines Agency’s (EMA): Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Pomalidomide Celgene in combination with dexamethasone for the treatment of relapsed and refractory multiple myeloma (rrMM) in patients who have received at least two prior therapies, including both lenalidomide and bortezomib, and have demonstrated disease progression while on their last therapy.
Sign-up for Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma investment picks
2013/2/5
Oral-B ® , a worldwide leader in the brushing market, announced today the launch of its newest rechargeable power (electric) toothbrush to the popular Professional Series line-up: the Professional™ Series Deep Sweep™ TRIACTION™. The new Oral-B Deep Sweep TRIACTION toothbrush is a breakthrough in brushing – the first of its kind in the United States to combine the familiar brushing motion of a manual brush with the comprehensive power of advanced triple zone cleaning action to cover more surface area and remove up to 100 percent more plaque vs.
Sign-up for Oral-B® Introduces First of Its Kind Power Toothbrush to the United States investment picks
2013/6/3
Oral-B is honoring dads everywhere this Father's Day.
Sign-up for Oral-B® Unveils Special Initiatives to Keep Dads Smiling This Father’s Day investment picks
2013/4/22
JERUSALEM , April 22, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a developer of oral delivery systems, announced today that the Company's CEO Nadav Kidron has been invited to be a panelist for a breakouts session at the BIO International Convention in Chicago, Illinois , USA.
Sign-up for Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader investment picks
2013/5/28
JERUSALEM , May 28, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a developer of oral drug delivery systems, announced today that the company's CEO, Nadav Kidron , has been invited to be a speaker at two key events in New York and Los Angeles .
Sign-up for Oramed CEO to Present at New York Biotechnology Association and The Israel Conference's Fast & Cool™ Session investment picks
2013/4/16
JERUSALEM , April 16, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a developer of oral drug delivery systems, today announced a key addition to its executive leadership team with the appointment of Joshua Hexter as Chief Operating Officer and Vice President of Business Development.
Sign-up for Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development investment picks
2013/5/30
JERUSALEM , May 30, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a developer of oral drug delivery systems, announced today that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant from the Office of the Chief Scientist ("OCS") at the Ministry of Industry, Trade and Labor of Israel .
Sign-up for Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel investment picks
2013/4/18
JERUSALEM , April 18, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a developer of oral delivery systems, announced today that its abstract, titled "Oral insulin may be effective in lowering hepatic insulin resistance and inflammation in patients with type 2 diabetes," has been selected for poster presentation at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria .
Sign-up for Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Oracle Introduces Oracle's Primavera Gateway to Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity